IMPACT OF LIPOFUSCIN IN RETINAL PIGMENT EPITHELIAL CELLS
脂褐质对视网膜色素上皮细胞的影响
基本信息
- 批准号:6086563
- 负责人:
- 金额:$ 25.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-05-01 至 2003-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Verbatim from applicant's abstract): A prominent feature of aging
and of some inherited retinal degenerations is the accumulation of
autofluorescent granules of lipofuscin in retinal pigmented epithelial (RPE)
cells. Circumstantial evidence exists for an association between age-related
macular degeneration (AMD) and RPE lipofuscin; however, the impact of
lipofuscin accumulation on the RPE cell has not been directly tested. Since one
of the constituents of RPE lipofuscin, the fluorophore A2E, exhibits structural
and photodynamic properties that could be detrimental to cells, it is
hypothesized that the accumulation of this fluorophore in RPE cells plays a
role in the pathogenesis of AMD. The aim of this work is to understand the
mechanisms by which A2E forms in the RPE cell and to determine the impact of
its accumulation on the RPE cell. By high performance liquid chromatography
(HPLC) analysis, the quantities of A2E in RPE cells isolated from human eyes
will be correlated with the age, race and gender of the donors. A2E in eyes
from AMD donors will also be quantified. To develop a cell culture model of
A2E-containing cells, cultured RPE lacking endogenous A2E will be presented
with synthetic A2E in the culture media. Subsequently, the internalization of
A2E by the cells will be characterized, as will the intracellular
compartmentalization of A2E. To test the hypothesis that A2E, when present at
critical concentrations, can have adverse effects on RPE cells, the propensity
of intracellular A2E to (a) exhibit detergent-like activity, (b) damage cells
as a photosensitizing agent and (c) disrupt lysosomal function, will be
evaluated. It will also be determined whether A2E-mediated phototoxicity
involves the generation of reactive oxidant species and an apoptotic form of
RPE cell death. The ability of melanin pigment to protect against A2E-mediated
phototoxicity will also be tested. Finally, in studies related to the
biogenesis of A2E, we will obtain evidence for the formation of an intermediate
compound (A2-PE) during A2E biosynthesis. We will also address the issue of
whether A2-PE/A2E is formed in the photoreceptor outer segment membrane as
opposed to the lysosomal compartment of the RPE cell. The long-term goal of
these studies is to define conditions that accelerate the formation of A2E in
vivo and to evaluate the role of A2E in the causation of AMD. If it can be
demonstrated that the amassing of synthetic A2E by RPE cells is significant in
terms of RPE cell function, treatments could be aimed at preventing its
formation or destroying the formed molecule within the RPE cells.
描述(逐字摘自申请者的摘要):老龄化的一个显著特征
一些遗传性视网膜退行性变是积累的
视网膜色素上皮(RPE)中脂褐素的自发荧光颗粒
细胞。存在间接证据表明与年龄相关的
黄斑变性(AMD)和RPE脂褐素;然而,
脂褐素在RPE细胞上的蓄积尚未得到直接测试。从一开始
在RPE脂褐素的成分中,荧光团A2E显示出结构
以及可能对细胞有害的光动力学特性,它是
假设这种荧光团在RPE细胞中的积累起到了
在AMD发病机制中的作用。这项工作的目的是了解
A2E在RPE细胞中形成的机制以及确定
它在RPE细胞上的积聚。通过高效液相色谱
高效液相色谱法测定人眼RPE细胞中A2E的含量
将与捐赠者的年龄、种族和性别相关。眼睛里的A2E
来自AMD捐赠者的数据也将被量化。为了开发一种细胞培养模型
含A2E的细胞,缺乏内源性A2E的培养的RPE
在培养基中加入合成的A2E。随之而来的是,内化
A2E将由细胞和细胞内的A2E来表征
A2E的区隔。以检验假设,当A2E存在于
临界浓度,会对RPE细胞产生不利影响,倾向于
细胞内A2E的作用:(A)表现出类似洗涤剂的活性,(B)损伤细胞
作为光敏剂和(C)扰乱溶酶体功能,
已评估。还将确定A2E介导的光毒性
涉及活性氧化剂物种的产生和一种凋亡形式的
RPE细胞死亡。黑色素对A2E介导的损伤的保护作用
还将进行光毒性测试。最后,在与
A2E的生物发生,我们将获得中间体形成的证据
A2E生物合成过程中的化合物(A2-PE)。我们还将解决以下问题
光感受器外节膜上是否形成A2-PE/A2E
与RPE细胞的溶酶体室相对。的长期目标是
这些研究旨在确定加速体内A2E形成的条件。
并评价A2E在AMD发病机制中的作用。如果可以的话
证明RPE细胞积聚合成的A2E在
在RPE细胞功能方面,治疗的目的可能是预防其
在RPE细胞内形成或破坏形成的分子。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Janet Ruthe Sparrow其他文献
Janet Ruthe Sparrow的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Janet Ruthe Sparrow', 18)}}的其他基金
Precision genome surgery in autologous stem cell transplant
自体干细胞移植中的精准基因组手术
- 批准号:
9811117 - 财政年份:2019
- 资助金额:
$ 25.15万 - 项目类别:
Retinal Disease Promoted by Iron-Induced Bisretinoid Oxidation
铁诱导的双维A酸氧化促进视网膜疾病
- 批准号:
10402760 - 财政年份:2018
- 资助金额:
$ 25.15万 - 项目类别:
Retinal Disease Promoted by Iron-Induced Bisretinoid Oxidation
铁诱导的双维A酸氧化促进视网膜疾病
- 批准号:
10090468 - 财政年份:2018
- 资助金额:
$ 25.15万 - 项目类别:
Quantitative Fundus Autofluorescence in Retinal Disorders
视网膜疾病中的定量眼底自发荧光
- 批准号:
10358501 - 财政年份:2014
- 资助金额:
$ 25.15万 - 项目类别:
Quantitative Fundus Autofluorescence in Retinal Disorders
视网膜疾病中的定量眼底自发荧光
- 批准号:
8619402 - 财政年份:2014
- 资助金额:
$ 25.15万 - 项目类别:
Quantitative Fundus Autofluorescence in Retinal Disorders
视网膜疾病中的定量眼底自发荧光
- 批准号:
9084593 - 财政年份:2014
- 资助金额:
$ 25.15万 - 项目类别:
Imaging, Histology and Functional Diagnostics Core
影像、组织学和功能诊断核心
- 批准号:
10273969 - 财政年份:2010
- 资助金额:
$ 25.15万 - 项目类别:
Imaging, Histology and Functional Diagnostics Core
影像、组织学和功能诊断核心
- 批准号:
10475818 - 财政年份:2010
- 资助金额:
$ 25.15万 - 项目类别:
Imaging, Histology and Functional Diagnostics Core
影像、组织学和功能诊断核心
- 批准号:
10681428 - 财政年份:2010
- 资助金额:
$ 25.15万 - 项目类别:
Impact of Lipofuscin in Retinal Pigment Epithelial Cells
脂褐素对视网膜色素上皮细胞的影响
- 批准号:
7523804 - 财政年份:2000
- 资助金额:
$ 25.15万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 25.15万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 25.15万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 25.15万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 25.15万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 25.15万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 25.15万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 25.15万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 25.15万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 25.15万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 25.15万 - 项目类别:














{{item.name}}会员




